Macquarie Healthcare’s pros and cons continue to offset each other, and the strategy retains its Average People and Process ratings.
Nomura Healthcare Fund Class A DLHAX
- NAV / 1-Day Return $29.02 / +1.33 %
- Fund Size $793.2M
- Adjusted Expense Ratio 1.210%
- Net Expense Ratio 1.210%
- Fee Level: Distribution Average
- Share Class Type Front Load
- Morningstar Category Health
- Equity Style Box (Funds) Mid Value
- Minimum Initial Investment $1,000
- Investment Status Open
- TTM Yield 2.21%
- Turnover Ratio 4%
Morningstar’s Analysis DLHAX
Will DLHAX outperform in the future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 38.4
|
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
|---|---|---|---|
Pfizer Inc | 4.41 | 34M | Healthcare |
UCB SA | 4.18 | 33M | Healthcare |
AbbVie Inc | 4.12 | 32M | Healthcare |
Merck & Co Inc | 4.08 | 32M | Healthcare |
Gilead Sciences Inc | 3.95 | 31M | Healthcare |
Regeneron Pharmaceuticals Inc | 3.90 | 30M | Healthcare |
Eli Lilly and Co | 3.86 | 30M | Healthcare |
UnitedHealth Group Inc | 3.50 | 27M | Healthcare |
Sanofi SA | 3.21 | 25M | Healthcare |
Elevance Health Inc | 3.18 | 25M | Healthcare |